SU‐FF‐J‐19: V‐Q SPECT to Individualize Adaptive Radiation Plan in Patients with Non‐Small Cell Lung Cancer (NSCLC)

F. Kong, S. Yuan, J. Moran, D. Tatro, C. Lochart, R. Ten Haken

Research output: Contribution to journalArticle

Abstract

Purposes: This study aimed to assess the changes of lung ventilation (V) and perfusion (Q) function by single photon emission tomography (V/Q SPECT) at 45 Gy during radiation therapy (RT), and determine if V/Q SPECT during‐RT can be used to decrease dose to the functioning lung. Methods: V/Q SPECT‐CT and FDG‐PET‐CT were performed prior and during‐RT (@45Gy) for patients enrolled in prospective clinical trials for stage I–III NSCLC. The V and Q functions were assessed using a semi‐quantitative system. An adaptive plan was generated after RT of 45 Gy to the target based on the during‐RT FDG‐PET‐CT. The during‐RT SPECT was used to optimize the plan to minimize dose to the functioning lung. Results: Of 45 patients analyzed, 100% had lung functional defects at or around the primary tumor and the majority of them have defects in the remaining lung. The V/Q defects were mismatched in 40% and 50% patients for pre‐ and during‐RT SPECT, respectively. After 45 Gy, the global and local lung function improved in one third patients. Specifically, there was a significant improvement in V scores in ipsilateral lung (P=0.002), while there was no significant changes in V scores of the contralateral lung and Q scores of the ipsilateral lung at or around the tumor at 45 Gy during‐RT. Using V/Q SPECT at 45 Gy for voxel based optimization, the mean dose to the functioning lung decreased remarkably while maintaining the physical dose to the target and the physical dose based lung normal tissue complication probability. Conclusion: V/Q SPECT‐CT acquired during the course of treatment has a potential to escalate the tumor dose and or decrease the dose to the functioning lung. Clinical trials are ongoing to assess if the therapeutic ratio (long‐term survival over lung toxicity) will improve in patients with NSCLC.

Original languageEnglish (US)
Pages (from-to)2479
Number of pages1
JournalMedical Physics
Volume36
Issue number6
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Single-Photon Emission-Computed Tomography
Non-Small Cell Lung Carcinoma
Radiation
Lung
Radiotherapy
Clinical Trials
Radiation Dosage
Neoplasms
Photons
Ventilation
Perfusion
Tomography

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐FF‐J‐19 : V‐Q SPECT to Individualize Adaptive Radiation Plan in Patients with Non‐Small Cell Lung Cancer (NSCLC). / Kong, F.; Yuan, S.; Moran, J.; Tatro, D.; Lochart, C.; Ten Haken, R.

In: Medical Physics, Vol. 36, No. 6, 2009, p. 2479.

Research output: Contribution to journalArticle

Kong, F. ; Yuan, S. ; Moran, J. ; Tatro, D. ; Lochart, C. ; Ten Haken, R. / SU‐FF‐J‐19 : V‐Q SPECT to Individualize Adaptive Radiation Plan in Patients with Non‐Small Cell Lung Cancer (NSCLC). In: Medical Physics. 2009 ; Vol. 36, No. 6. pp. 2479.
@article{30ba2f81f03248b68fe39fb80a3b570d,
title = "SU‐FF‐J‐19: V‐Q SPECT to Individualize Adaptive Radiation Plan in Patients with Non‐Small Cell Lung Cancer (NSCLC)",
abstract = "Purposes: This study aimed to assess the changes of lung ventilation (V) and perfusion (Q) function by single photon emission tomography (V/Q SPECT) at 45 Gy during radiation therapy (RT), and determine if V/Q SPECT during‐RT can be used to decrease dose to the functioning lung. Methods: V/Q SPECT‐CT and FDG‐PET‐CT were performed prior and during‐RT (@45Gy) for patients enrolled in prospective clinical trials for stage I–III NSCLC. The V and Q functions were assessed using a semi‐quantitative system. An adaptive plan was generated after RT of 45 Gy to the target based on the during‐RT FDG‐PET‐CT. The during‐RT SPECT was used to optimize the plan to minimize dose to the functioning lung. Results: Of 45 patients analyzed, 100{\%} had lung functional defects at or around the primary tumor and the majority of them have defects in the remaining lung. The V/Q defects were mismatched in 40{\%} and 50{\%} patients for pre‐ and during‐RT SPECT, respectively. After 45 Gy, the global and local lung function improved in one third patients. Specifically, there was a significant improvement in V scores in ipsilateral lung (P=0.002), while there was no significant changes in V scores of the contralateral lung and Q scores of the ipsilateral lung at or around the tumor at 45 Gy during‐RT. Using V/Q SPECT at 45 Gy for voxel based optimization, the mean dose to the functioning lung decreased remarkably while maintaining the physical dose to the target and the physical dose based lung normal tissue complication probability. Conclusion: V/Q SPECT‐CT acquired during the course of treatment has a potential to escalate the tumor dose and or decrease the dose to the functioning lung. Clinical trials are ongoing to assess if the therapeutic ratio (long‐term survival over lung toxicity) will improve in patients with NSCLC.",
author = "F. Kong and S. Yuan and J. Moran and D. Tatro and C. Lochart and {Ten Haken}, R.",
year = "2009",
doi = "10.1118/1.3181311",
language = "English (US)",
volume = "36",
pages = "2479",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐FF‐J‐19

T2 - V‐Q SPECT to Individualize Adaptive Radiation Plan in Patients with Non‐Small Cell Lung Cancer (NSCLC)

AU - Kong, F.

AU - Yuan, S.

AU - Moran, J.

AU - Tatro, D.

AU - Lochart, C.

AU - Ten Haken, R.

PY - 2009

Y1 - 2009

N2 - Purposes: This study aimed to assess the changes of lung ventilation (V) and perfusion (Q) function by single photon emission tomography (V/Q SPECT) at 45 Gy during radiation therapy (RT), and determine if V/Q SPECT during‐RT can be used to decrease dose to the functioning lung. Methods: V/Q SPECT‐CT and FDG‐PET‐CT were performed prior and during‐RT (@45Gy) for patients enrolled in prospective clinical trials for stage I–III NSCLC. The V and Q functions were assessed using a semi‐quantitative system. An adaptive plan was generated after RT of 45 Gy to the target based on the during‐RT FDG‐PET‐CT. The during‐RT SPECT was used to optimize the plan to minimize dose to the functioning lung. Results: Of 45 patients analyzed, 100% had lung functional defects at or around the primary tumor and the majority of them have defects in the remaining lung. The V/Q defects were mismatched in 40% and 50% patients for pre‐ and during‐RT SPECT, respectively. After 45 Gy, the global and local lung function improved in one third patients. Specifically, there was a significant improvement in V scores in ipsilateral lung (P=0.002), while there was no significant changes in V scores of the contralateral lung and Q scores of the ipsilateral lung at or around the tumor at 45 Gy during‐RT. Using V/Q SPECT at 45 Gy for voxel based optimization, the mean dose to the functioning lung decreased remarkably while maintaining the physical dose to the target and the physical dose based lung normal tissue complication probability. Conclusion: V/Q SPECT‐CT acquired during the course of treatment has a potential to escalate the tumor dose and or decrease the dose to the functioning lung. Clinical trials are ongoing to assess if the therapeutic ratio (long‐term survival over lung toxicity) will improve in patients with NSCLC.

AB - Purposes: This study aimed to assess the changes of lung ventilation (V) and perfusion (Q) function by single photon emission tomography (V/Q SPECT) at 45 Gy during radiation therapy (RT), and determine if V/Q SPECT during‐RT can be used to decrease dose to the functioning lung. Methods: V/Q SPECT‐CT and FDG‐PET‐CT were performed prior and during‐RT (@45Gy) for patients enrolled in prospective clinical trials for stage I–III NSCLC. The V and Q functions were assessed using a semi‐quantitative system. An adaptive plan was generated after RT of 45 Gy to the target based on the during‐RT FDG‐PET‐CT. The during‐RT SPECT was used to optimize the plan to minimize dose to the functioning lung. Results: Of 45 patients analyzed, 100% had lung functional defects at or around the primary tumor and the majority of them have defects in the remaining lung. The V/Q defects were mismatched in 40% and 50% patients for pre‐ and during‐RT SPECT, respectively. After 45 Gy, the global and local lung function improved in one third patients. Specifically, there was a significant improvement in V scores in ipsilateral lung (P=0.002), while there was no significant changes in V scores of the contralateral lung and Q scores of the ipsilateral lung at or around the tumor at 45 Gy during‐RT. Using V/Q SPECT at 45 Gy for voxel based optimization, the mean dose to the functioning lung decreased remarkably while maintaining the physical dose to the target and the physical dose based lung normal tissue complication probability. Conclusion: V/Q SPECT‐CT acquired during the course of treatment has a potential to escalate the tumor dose and or decrease the dose to the functioning lung. Clinical trials are ongoing to assess if the therapeutic ratio (long‐term survival over lung toxicity) will improve in patients with NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=85024808695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024808695&partnerID=8YFLogxK

U2 - 10.1118/1.3181311

DO - 10.1118/1.3181311

M3 - Article

AN - SCOPUS:85024808695

VL - 36

SP - 2479

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -